22 May 2013
Keywords: genpath, merck, co, sign, oncology, deal, pharmaceuticals
Article | 24 November 2003
GenPath Pharmaceuticals has signed a collaborative agreement with drugmajor Merck & Co in the field of oncology, under which the former ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
24 November 2003
© 2013 thepharmaletter.com